Cargando…

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world

The Bacillus Calmette-Guérin (BCG) vaccine is a free vaccine in China, and more than 300 million newborns have been vaccinated. Inevitably, the BCG vaccine will have some rare adverse events on the first day of life (24 hours after birth), but related reports are extremely rare. In this commentary,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Jinmiao, Zhang, Xunjie, Xu, Hong, Li, Zhiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Licensed Vaccines – Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621010/ https://www.ncbi.nlm.nih.gov/pubmed/35687363 http://dx.doi.org/10.1080/21645515.2022.2080443

Ejemplares similares

Epidemiological characteristics and trends of Bacillus Calmette–Guérin lymphadenitis in Shanghai, China from 2010 to 2019
por: Wang, Jing, et al.
Publicado: (2021)

VARIABILITY OF BCG STRAINS (BACILLUS CALMETTE-GUÉRIN)
por: Suter, W. Emanuel, et al.
Publicado: (1951)

Bacillus Calmette-Guerin (BCG) vaccine in Iran
por: Fallah, Fatemeh, et al.
Publicado: (2018)

Bacillus Calmette-Guerin (BCG): the adroit vaccine
por: Adesanya, Oluwafolajimi A., et al.
Publicado: (2021)

ASVAC2022 : 8(th) Asian Vaccine Conference
por: Galagoda, Geethani C. S., et al.
Publicado: (2023)

Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases
por: Van den Steen, Peter, et al.
Publicado: (2023)

Mumps-specific antibody persistence in children aged 3–7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China
por: Sun, Jinfang, et al.
Publicado: (2023)

Public health impact of herpes zoster vaccination on older adults in Hong Kong
por: Chan, Paul K. S., et al.
Publicado: (2023)

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
por: Sun, Dapeng, et al.
Publicado: (2023)

Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review
por: Knuf, Markus, et al.
Publicado: (2023)

Trends in research related to vaccine and cancer prevention from 1992 to 2022: A 30-years bibliometric analysis
por: Zhang, Luofei, et al.
Publicado: (2023)

Reduced reactogenicity of primary vaccination with DT3aP-HBV-IPV/Hib compared with DT2aP-HBV-IPV-Hib among infants: Mathematical projections in six countries
por: George, Marina, et al.
Publicado: (2023)

Seroprevalence rates in children aged 3-6 years after implementing a two-dose varicella vaccination: A observational study
por: Zhang, Zhuoyu, et al.
Publicado: (2023)

Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella–zoster virus
por: Hwang, Ji-Young, et al.
Publicado: (2023)

Measles vaccine uptake among Italian medical students compared to the pre-COVID-19 era
por: Ferrari, Cristiana, et al.
Publicado: (2023)

Measles vaccine uptake and COVID-19
por: Daungsupawong, Hinpetch, et al.
Publicado: (2023)

Improving Tdap maternal immunization rate in Saudi Arabia
por: Aldoosari, Agariad, et al.
Publicado: (2023)

An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox
por: Tomita, Noriko, et al.
Publicado: (2023)

Vaccination in preterm and low birth weight infants in India
por: Soans, Santosh, et al.
Publicado: (2021)

Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
por: Al-Hammadi, Suleiman, et al.
Publicado: (2017)

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
Publicado: (2021)

Adverse Events of the BCG (Bacillus Calmette–Guérin) and Rotavirus Vaccines in a Young Infant with Inborn Error of Immunity
por: Al-Hammadi, Suleiman, et al.
Publicado: (2020)

The world’s largest measles-Rubella vaccination campaign in Pakistan: Time to invest in routine immunization
por: Rana, Muhammad Suleman, et al.
Publicado: (2022)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
por: Pan, Xuejiao, et al.
Publicado: (2022)

Managing the adverse events of intravesical bacillus Calmette–Guérin therapy
por: Decaestecker, Karel, et al.
Publicado: (2015)

Changes in dendritic complexity and spine morphology following BCG immunization in APP/PS1 mice
por: Li, Qingqing, et al.
Publicado: (2022)

Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
por: Sbragia, Elvira, et al.
Publicado: (2022)

Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007)

Goldilocks and the BCG: Bacillus Calmette-Guérin Dose Reduction in the Age of Shortage
por: Nikas, Christine V., et al.
Publicado: (2020)

Inspiration to mRNA-based COVID-19 vaccination: Serious adverse case reports with hepatitis B vaccine in real-world
por: Lu, Jinmiao, et al.
Publicado: (2022)

Time to face the proofs: the BCG Moreau vaccine promotes superior inflammatory cytokine profile in vitro when compared with Russia, Pasteur, and Danish strains
por: da Silva, Andreon Santos Machado, et al.
Publicado: (2021)

Systemic Bacillus Calmette-Guérin (BCG) Infection With Renal Involvement: A Rare Complication of BCG Immunotherapy
por: Afonso, Raquel, et al.
Publicado: (2022)

Advances in the progress of monoclonal antibodies for rabies
por: Fan, Linlin, et al.
Publicado: (2022)

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines
por: Montalvo Zurbia-Flores, Gerardo, et al.
Publicado: (2021)

The progress of postapproval clinical studies on Sabin IPV
por: Shi, Li, et al.
Publicado: (2021)

Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review
por: MacDonald, Shannon E., et al.
Publicado: (2021)

Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
por: Khan, Sadaf, et al.
Publicado: (2021)

Burden of vaccine-preventable diseases among at-risk adult populations in the US
por: Kolobova, Irina, et al.
Publicado: (2022)

Commentary on the implications of safety and efficacy studies in pediatric patients with administration of human rabies immune globulin (HRIG)?
por: Siegel, Jerry, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5slsff75o9u5sg5oa9sb3s3h1q